The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is
widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs) …

An important goal of the health system is to identify new adverse drug events (ADEs) in the
postapproval period. Data‐mining methods that can transform data into meaningful …

The discovery and generation of effective therapeutics to combat disease lies at the heart of
biomedical research. Preclinical studies form the foundation of potential disease treatments …

Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …

Genome-wide association (GWA) studies for pharmacogenomics-related traits are
increasingly being performed to identify loci that affect either drug response or susceptibility …

LamZiziphora clinopodioides Biosynthesis of metal nanoparticles using plant medicine is
under exploration is due to wide biomedica applications and research interest in …

One approach to experimental science involves creating hypotheses, then testing them by
varying one or more independent variables, and assessing the effects of this variation on the …

Leishmaniasis remains a public health problem worldwide, affecting approximately 12
million people in 88 countries; 50 000 die of it each year. The disease is caused by …

Drug-induced liver injury (DILI) is among the most challenging acute or chronic liver
conditions to be handled by physicians. Despite its low incidence in the general population …

The circadian timing system drives daily rhythmic changes in drug metabolism and controls
rhythmic events in cell cycle, DNA repair, apoptosis, and angiogenesis in both normal tissue …